Inspire has achieved a significant milestone with the FDA approval of its Inspire V therapy system, an integral part of the company’s therapy system for treating obstructive sleep apnoea (OSA). This development underscores a growing trend towards integrating sophisticated technology in managing neurological conditions, aligning with the wider industry’s movement towards precision medicine.

According to GlobalData, the market for neurological devices was valued at $12.5bn in 2023 and is expected to grow by a CAGR of 4.60% to reach $20.9bn by 2033. This growth underscores the increasing importance and demand for advanced diagnostic and monitoring technologies in neurology, including those targeting Parkinson’s disease.

Reflecting on the recent focus on wearable technologies and digital health apps—such as those that utilise Apple Watch data for monitoring Parkinson’s symptoms—shows a parallel path of innovation. While wearable technologies offer continuous monitoring outside clinical settings, advanced tools like Inspire’s neurostimulator enhance therapeutic interventions, providing a comprehensive approach to disease management.

The integration of advanced software in medical devices and the use of AI in developing diagnostic and monitoring tools are setting new standards in the treatment and management of neurological disorders. Future initiatives may focus on expanding the adoption of DBS and similar technologies by demonstrating their effectiveness and efficiency in clinical settings.

Inspire’s latest achievement with its Inspire V therapy system not only marks a significant advancement in OSA treatment technology but also aligns with the broader trend towards high-tech solutions in healthcare. This development, alongside ongoing innovations in wearable technology and digital health, signifies a promising shift towards more personalised and effective management of neurological conditions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.